Noramco, Inc. acquired Halo Pharma, Inc. from Cambrex Corporation on November 2, 2023. Almost 400 new employees will join the Noramco group of companies.
Noramco, Inc. completed the acquisition of Halo Pharma, Inc. from Cambrex Corporation on November 2, 2023. Matthew Mamak, John Snyder, Clay Littlefield, Brett Coburn, Brendan Carroll, Dan Felz, Ronnie Gosselin, Blake MacKay, and Alix Marzelli of Alston & Bird LLP acted as legal advisors to Noramco, Inc. in the deal.